-DOCSTART- -X- O
Associations -X- _ O
between -X- _ O
respiratory -X- _ O
infections -X- _ O
and -X- _ O
asthma -X- _ O
inception -X- _ O
and -X- _ O
exacerbations -X- _ O
are -X- _ O
well -X- _ O
established. -X- _ O
Infant -X- _ O
respiratory -X- _ O
syncytial -X- _ O
virus -X- _ O
and -X- _ O
rhinovirus -X- _ O
infections -X- _ O
are -X- _ O
known -X- _ O
to -X- _ O
be -X- _ O
associated -X- _ O
with -X- _ O
an -X- _ O
increased -X- _ O
risk -X- _ O
of -X- _ O
asthma -X- _ O
development -X- _ O
, -X- _ O
and -X- _ O
among -X- _ O
children -X- _ O
with -X- _ O
prevalent -X- _ O
asthma -X- _ O
, -X- _ O
85 -X- _ O
% -X- _ O
of -X- _ O
asthma -X- _ O
exacerbations -X- _ O
are -X- _ O
associated -X- _ O
with -X- _ O
viral -X- _ O
infections. -X- _ O
However -X- _ O
, -X- _ O
the -X- _ O
exact -X- _ O
nature -X- _ O
of -X- _ O
this -X- _ O
relationship -X- _ O
remains -X- _ O
unclear. -X- _ O
Is -X- _ O
the -X- _ O
increase -X- _ O
in -X- _ O
severity -X- _ O
of -X- _ O
infections -X- _ O
an -X- _ O
epiphenomenon -X- _ O
, -X- _ O
meaning -X- _ O
respiratory -X- _ O
infections -X- _ O
just -X- _ O
appear -X- _ O
more -X- _ O
severe -X- _ O
in -X- _ O
individuals -X- _ O
with -X- _ O
underlying -X- _ O
respiratory -X- _ O
disease -X- _ O
, -X- _ O
or -X- _ O
instead -X- _ O
a -X- _ O
reflection -X- _ O
of -X- _ O
altered -X- _ O
host -X- _ O
susceptibility -X- _ O
among -X- _ O
persons -X- _ B-Patient
with -X- _ I-Patient
asthma -X- _ I-Patient
and -X- _ I-Patient
atopic -X- _ I-Patient
disease -X- _ I-Patient
? -X- _ O
The -X- _ O
main -X- _ O
focus -X- _ O
of -X- _ O
this -X- _ O
review -X- _ O
is -X- _ O
to -X- _ O
summarize -X- _ O
the -X- _ O
available -X- _ O
levels -X- _ O
of -X- _ O
evidence -X- _ O
supporting -X- _ O
or -X- _ O
refuting -X- _ O
the -X- _ O
notion -X- _ O
that -X- _ O
persons -X- _ O
with -X- _ O
asthma -X- _ O
or -X- _ O
atopic -X- _ O
disease -X- _ O
have -X- _ B-Outcome
an -X- _ I-Outcome
altered -X- _ I-Outcome
susceptibility -X- _ I-Outcome
to -X- _ I-Outcome
selected -X- _ I-Outcome
pathogens -X- _ I-Outcome
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
discussing -X- _ O
the -X- _ O
biological -X- _ O
mechanism -X- _ O
( -X- _ O
s -X- _ O
) -X- _ O
that -X- _ O
might -X- _ O
explain -X- _ O
such -X- _ O
associations. -X- _ O
Finally -X- _ O
, -X- _ O
we -X- _ O
will -X- _ O
outline -X- _ O
areas -X- _ O
in -X- _ O
need -X- _ O
of -X- _ O
further -X- _ O
research -X- _ O
, -X- _ O
as -X- _ O
understanding -X- _ O
the -X- _ O
relationships -X- _ O
between -X- _ O
infections -X- _ O
and -X- _ O
asthma -X- _ O
has -X- _ O
important -X- _ O
implications -X- _ O
for -X- _ O
both -X- _ O
asthma -X- _ O
prevention -X- _ O
and -X- _ O
treatment -X- _ O
, -X- _ O
including -X- _ O
potential -X- _ O
new -X- _ O
pathways -X- _ O
that -X- _ O
might -X- _ O
target -X- _ O
host -X- _ O
immune -X- _ O
response -X- _ O
to -X- _ O
select -X- _ O
pathogens -X- _ O
. -X- _ O

